Saitoh Y, Mori H, Matsumoto K, Ushio Y, Hayakawa T, Mori S, Arita N, Mogami H
Acta Neuropathol. 1985;68(2):87-92. doi: 10.1007/BF00688628.
The accumulation of amyloid in pituitary adenomas was examined in relation to the types of adenoma and the effect of bromocriptine treatment. Amyloid had accumulated in 34 of 48 adenomas (71%). The occurrence in prolactin-secreting adenomas and growth hormone-secreting adenomas was 79%, respectively, while that in non-functioning adenomas was 50%. Treatment with bromocriptine enhanced the occurrence and extent of the amyloid accumulation in prolactin- or growth hormone-secreting adenomas. Electron microscopy revealed the initial appearance of the amyloid fibrils in the smooth endoplasmic reticulum and a possible sequential process of their release from the cells. The presence of secretory granules in vesicles containing amyloid fibrils and their simultaneous release with amyloid fibrils suggested that degradation of secretory granules was involved in the formation of amyloid.
研究了垂体腺瘤中淀粉样蛋白的积累与腺瘤类型及溴隐亭治疗效果的关系。48例腺瘤中有34例(71%)出现淀粉样蛋白积累。泌乳素分泌型腺瘤和生长激素分泌型腺瘤的发生率分别为79%,而无功能腺瘤的发生率为50%。溴隐亭治疗可增加泌乳素或生长激素分泌型腺瘤中淀粉样蛋白积累的发生率和程度。电子显微镜显示淀粉样原纤维最初出现在滑面内质网中,并可能存在从细胞中释放的连续过程。含有淀粉样原纤维的囊泡中存在分泌颗粒,且它们与淀粉样原纤维同时释放,这表明分泌颗粒的降解参与了淀粉样蛋白的形成。